The incidence and geographic distribution of Lyme disease in the U.S. has increased steadily since its first description in 1977. Efforts to stem the spread of the disease through controlling the population of its tick vector and/or the mouse reservoirs of the disease have met with only limited success. The only approved human vaccine to protect against Lyme disease was recently removed from the market by its manufacturer further highlighting the need for new approaches to controlling the disease. In this project, we propose the development of an orally- available vaccine targeted towards the mouse and tick reservoirs of the disease. The project is modeled on the highly successful oral rabies vaccine, Raboral, which uses a vaccinia virus (VV) vector to deliver its immunogen to wild foxes and raccoons. We will take advantage of the enormous amount of immunogenicity and safety data that has been generated for vaccinia virus in hopes of rapidly developing a release-able vaccine. The vaccine itself will consist of outer surface protein A (OspA) recombinantly expressed from a VV vector. OspA was the antigen used in the human vaccine. Extensive research has shown that it is immunogenic in mice, that mice vaccinated against OspA are protected against infection with Borrelia burgdorferi and that B. burgdorferi infected ticks feeding on mice vaccinated with OspA are sterilized of their infection and cannot transmit the disease to other animals. Prior attempts to use OspA to vaccinate wild animals have been hampered by the lack of an efficient, oral delivery system which is both stable under natural environmental conditions and can generate an intense immune response. The three aims of this project are to: 1) create a recombinant VV expressing OspA (W/OspA); 2) establish the kinetics and durability of the immune response to the recombinant W/OspA; and 3) test the efficacy of W/OspA administered orally in preventing transmission of B. burgdorferi to mice and in sterilizing infection in infected ticks.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01AI058266-01
Application #
6734116
Study Section
Special Emphasis Panel (ZAI1-GSM-M (S3))
Program Officer
Baker, Phillip J
Project Start
2003-09-01
Project End
2007-02-28
Budget Start
2003-09-01
Budget End
2004-02-29
Support Year
1
Fiscal Year
2003
Total Cost
$107,124
Indirect Cost
Name
Tufts University
Department
Type
DUNS #
079532263
City
Boston
State
MA
Country
United States
Zip Code
02111
Scheckelhoff, Mark R; Telford, Sam R; Wesley, Mary et al. (2007) Borrelia burgdorferi intercepts host hormonal signals to regulate expression of outer surface protein A. Proc Natl Acad Sci U S A 104:7247-52
Scheckelhoff, Mark R; Telford, Sam R; Hu, Linden T (2006) Protective efficacy of an oral vaccine to reduce carriage of Borrelia burgdorferi (strain N40) in mouse and tick reservoirs. Vaccine 24:1949-57
Behera, Aruna K; Hildebrand, Ethan; Uematsu, Satoshi et al. (2006) Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol 177:657-64
Behera, Aruna K; Hildebrand, Ethan; Szafranski, Jon et al. (2006) Role of aggrecanase 1 in Lyme arthritis. Arthritis Rheum 54:3319-29
Behera, Aruna K; Hildebrand, Ethan; Bronson, Roderick T et al. (2006) MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun 74:1462-70
Behera, Aruna K; Hildebrand, Ethan; Scagliotti, Joanna et al. (2005) Induction of host matrix metalloproteinases by Borrelia burgdorferi differs in human and murine lyme arthritis. Infect Immun 73:126-34
Behera, Aruna K; Thorpe, Cheleste M; Kidder, J Michael et al. (2004) Borrelia burgdorferi-induced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infect Immun 72:2864-71
Wang, Xing-Guo; Scagliotti, Joanna P; Hu, Linden T (2004) Phospholipid synthesis in Borrelia burgdorferi: BB0249 and BB0721 encode functional phosphatidylcholine synthase and phosphatidylglycerolphosphate synthase proteins. Microbiology 150:391-7